{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:50:31Z","timestamp":1791946231398,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":959,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo para la Convergencia Estructural del Mercosur"},{"name":"Agencia Nacional de Investigacion e Inovacion"},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programa de Desarrollo de Ciencias Basicas"},{"name":"EOLO Pharma"},{"name":"National Institut of Neurological Disorders and Stroke"},{"name":"Department of Veternas Affairs"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s13311-020-00953-z","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T14:02:51Z","timestamp":1603893771000},"page":"309-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-\u03baB Inhibition"],"prefix":"10.1016","volume":"18","author":[{"given":"Sof\u00eda","family":"Ibarburu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1ngeles","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rodr\u00edguez-Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Ingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Williams","family":"Porcal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Perelmuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Bollati-Fogol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Escande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria V.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Batthy\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Barbeito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-511X","authenticated-orcid":false,"given":"Emiliano","family":"Trias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1007\/s13311-020-00953-z_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic Lateral Sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14660820310002601","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"4","author":"Miller","year":"2003","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"7","key":"10.1007\/s13311-020-00953-z_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib4","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"10.1007\/s13311-020-00953-z_bib5","doi-asserted-by":"crossref","first-page":"18126","DOI":"10.1073\/pnas.1110689108","article-title":"Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis","volume":"108","author":"Diaz-Amarilla","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00953-z_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2013.00274","article-title":"Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS","volume":"7","author":"Trias","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-020-00953-z_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2016.07.052","article-title":"Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis","volume":"636","author":"Trias","year":"2017","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-016-0620-9","article-title":"Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis","volume":"13","author":"Trias","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1-2","key":"10.1007\/s13311-020-00953-z_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678421.2019.1632346","article-title":"Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"21","author":"Mora","year":"2020","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001271","article-title":"NF-kappaB in the nervous system","volume":"1","author":"Kaltschmidt","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1007\/s13311-020-00953-z_bib12","doi-asserted-by":"crossref","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Targete Therapy 2017;2. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","DOI":"10.1038\/sigtrans.2017.23"},{"issue":"5","key":"10.1007\/s13311-020-00953-z_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron."},{"key":"10.1007\/s13311-020-00953-z_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","article-title":"Cellular Specificity of NF-kappaB Function in the Nervous System","volume":"10","author":"Dresselhaus","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871527316666170807130011","article-title":"NF-kappaB as a Key Mediator of Brain Inflammation in Alzheimer's Disease","volume":"18","author":"Ju Hwang","year":"2019","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"10.1007\/s13311-020-00953-z_bib16","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J Exp Med"},{"issue":"6","key":"10.1007\/s13311-020-00953-z_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5414\/NP300493","article-title":"Nuclear factor kappa B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations","volume":"31","author":"Sako","year":"2012","journal-title":"Clin Neuropathol"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib18","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41598-018-20460-8","article-title":"Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-kappaB signaling:A medicinal chemistry investigation of structure-function relationships","volume":"8","author":"Khoo","year":"2018","journal-title":"Sci Rep"},{"issue":"47","key":"10.1007\/s13311-020-00953-z_bib19","doi-asserted-by":"crossref","first-page":"35686","DOI":"10.1074\/jbc.M603357200","article-title":"Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators","volume":"281","author":"Cui","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00953-z_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.freeradbiomed.2016.03.013","article-title":"Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation","volume":"95","author":"Diaz-Amarilla","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib21","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1038\/s41598-018-31218-7","article-title":"Electrophilic nitroalkene-tocopherol derivatives: synthesis, physicochemical characterization and evaluation of anti-inflammatory signaling responses","volume":"8","author":"Rodriguez-Duarte","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1007\/s13311-020-00953-z_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/bph.14561","article-title":"A novel nitroalkene-alpha-tocopherol analogue inhibits inflammation and ameliorates atherosclerosis in Apo E knockout mice","volume":"176","author":"Rodriguez-Duarte","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj1180047","article-title":"The fate of benzoic acid in various species","volume":"118","author":"Bridges","year":"1970","journal-title":"Biochem J"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/siny.2001.0085","article-title":"Urea cycle disorders","volume":"7","author":"Leonard","year":"2002","journal-title":"Semin Neonatol"},{"issue":"6","key":"10.1007\/s13311-020-00953-z_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130398","article-title":"Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21rac and Protect Memory and Learning in an Animal Model of Alzheimer's Disease","volume":"10","author":"Modi","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1007\/s13311-020-00953-z_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11481-011-9286-3","article-title":"Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons","volume":"7","author":"Khasnavis","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6706","key":"10.1007\/s13311-020-00953-z_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature."},{"issue":"5291","key":"10.1007\/s13311-020-00953-z_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science."},{"key":"10.1007\/s13311-020-00953-z_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1007\/s13311-020-00953-z_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnim.2017.11.002","article-title":"Effects of consumption of whole grape powder on basal NF-kappaB signaling and inflammatory cytokine secretion in a mouse model of inflammation","volume":"11","author":"Miller","year":"2018","journal-title":"J Nutr Intermed Metabol"},{"key":"10.1007\/s13311-020-00953-z_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/860534","article-title":"HT-29 and Caco-2 reporter cell lines for functional studies of nuclear factor kappa B activation","volume":"2015","author":"Mastropietro","year":"2015","journal-title":"Mediat Inflamm"},{"issue":"47","key":"10.1007\/s13311-020-00953-z_bib32","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1523\/JNEUROSCI.2037-14.2014","article-title":"Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex","volume":"34","author":"Thomsen","year":"2014","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-020-00953-z_bib33","doi-asserted-by":"crossref","unstructured":"Trias E, Ibarburu S, Barreto-Nunez R, Varela V, Moura IC, Dubreuil P, et al. Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS. JCI Insight 2017;2(20). https:\/\/doi.org\/10.1172\/jci.insight.95934.","DOI":"10.1172\/jci.insight.95934"},{"key":"10.1007\/s13311-020-00953-z_bib34","doi-asserted-by":"crossref","unstructured":"Kovacs M, Trias E, Varela V, Ibarburu S, Beckman JS, Moura IC, et al. CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS. Int J Mol Sci 2019;20(16). https:\/\/doi.org\/10.3390\/ijms20163880.","DOI":"10.3390\/ijms20163880"},{"issue":"6","key":"10.1007\/s13311-020-00953-z_bib35","doi-asserted-by":"crossref","first-page":"e18904","DOI":"10.1097\/MD.0000000000018904","article-title":"Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant)","volume":"99","author":"Vucic","year":"2020","journal-title":"Medicine."},{"issue":"9","key":"10.1007\/s13311-020-00953-z_bib36","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.4049\/jimmunol.0803336","article-title":"Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses","volume":"183","author":"Brahmachari","year":"2009","journal-title":"J Immunol"},{"key":"10.1007\/s13311-020-00953-z_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2019.00042","article-title":"Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS","volume":"11","author":"Trias","year":"2019","journal-title":"Front Aging Neurosci"},{"issue":"Pt 2","key":"10.1007\/s13311-020-00953-z_bib38","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/brain\/114.2.775","article-title":"Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity","volume":"114","author":"Leigh","year":"1991","journal-title":"Brain J Neurol"},{"issue":"4","key":"10.1007\/s13311-020-00953-z_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ana.410420416","article-title":"Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis","volume":"42","author":"Beal","year":"1997","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/08923973.2010.547500","article-title":"Vanillic acid inhibits inflammatory mediators by suppressing NF-kappaB in lipopolysaccharide-stimulated mouse peritoneal macrophages","volume":"33","author":"Kim","year":"2011","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","article-title":"Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Patel","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1007\/s13311-020-00953-z_bib42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","article-title":"Inflammation in ALS\/FTD pathogenesis","volume":"137","author":"McCauley","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1007\/s13311-020-00953-z_bib43","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1002\/jcb.27884","article-title":"Ubiquitin-proteasome system and ER stress in the brain of diabetic rats","volume":"120","author":"Shruthi","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1007\/s13311-020-00953-z_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fnmol.2014.00070","article-title":"The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution","volume":"7","author":"Dantuma","year":"2014","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1523\/JNEUROSCI.18-03-00923.1998","article-title":"Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation","volume":"18","author":"Estevez","year":"1998","journal-title":"J Neurosci"},{"issue":"12","key":"10.1007\/s13311-020-00953-z_bib46","doi-asserted-by":"crossref","first-page":"e2499","DOI":"10.1038\/cddis.2016.389","article-title":"Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2\/ARE pathway in Alzheimer's disease models","volume":"7","author":"Lipton","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1007\/s13311-020-00953-z_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","article-title":"Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases","volume":"79","author":"Schopfer","year":"2018","journal-title":"Nitric Oxide Biol Chem"},{"key":"10.1007\/s13311-020-00953-z_bib48","doi-asserted-by":"crossref","first-page":"658520","DOI":"10.1155\/2008\/658520","article-title":"PPAR Regulation of Inflammatory Signaling in CNS Diseases","volume":"2008","author":"Bright","year":"2008","journal-title":"PPAR Res"},{"key":"10.1007\/s13311-020-00953-z_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease","volume":"100","author":"Corona","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1007\/s13311-020-00953-z_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1073\/pnas.0505723102","article-title":"Activation of the Keap1\/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers","volume":"103","author":"Satoh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1007\/s13311-020-00953-z_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-kappaB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1756285614564152","article-title":"Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview","volume":"8","author":"Bomprezzi","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib53","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/s41467-019-11139-3","article-title":"Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes","volume":"10","author":"Carlstrom","year":"2019","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-020-00953-z_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front Neurol"},{"issue":"7","key":"10.1007\/s13311-020-00953-z_bib55","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1074\/jbc.M115.679704","article-title":"Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein","volume":"291","author":"Kastrati","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-020-00953-z_bib56","doi-asserted-by":"crossref","unstructured":"Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight 2018;3(19). https:\/\/doi.org\/10.1172\/jci.insight.123249.","DOI":"10.1172\/jci.insight.123249"},{"issue":"4","key":"10.1007\/s13311-020-00953-z_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14660820410020286","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells","volume":"5","author":"Graves","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"issue":"12","key":"10.1007\/s13311-020-00953-z_bib58","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/hmg\/ddv093","article-title":"A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS","volume":"24","author":"Nagano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-020-00953-z_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","article-title":"Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD","volume":"89","author":"Williams","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1007\/s13311-020-00953-z_bib60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1602\/neurorx.2.1.54","article-title":"Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems","volume":"2","author":"Tsuji","year":"2005","journal-title":"NeuroRx"},{"key":"10.1007\/s13311-020-00953-z_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncel.2014.00021","article-title":"Blood-CNS Barrier Impairment in ALS patients versus an animal model","volume":"8","author":"Garbuzova-Davis","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.1007\/s13311-020-00953-z_bib62","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-020-00953-z_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1742-2094-11-104","article-title":"A role for human brain pericytes in neuroinflammation","volume":"11","author":"Jansson","year":"2014","journal-title":"J Neuroinflammation"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00953-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00953-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:59:24Z","timestamp":1761807564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923011996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1878747923011996"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00953-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-\u03baB Inhibition","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00953-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}